مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

235
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

136
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

CONTOVIR-A NEW ADJUVANT THERAPY IN RECURRENT RESPIRATORYPAPILLOMATOSIS: A CASE STUDY (RAPID COMMUNICATION)

Pages

  0-0

Keywords

RECURRENT RESPIRATORY PAPILLOMATOSIS (RRP) 

Abstract

 Background: CONTOVIR is a mixture of herbal extracts (Tanacetum vulgare, Rossa canina, Urtica dioica) that is supplemented withselenium. Objectives: This study aimed to add CONTOVIR to the classic treatment of recurrent respiratory papillomatosis (RRP) in order todecrease the severity and extent of the disease, elongate the surgical intervals and improve the sense of patient well-being. Furthermore, we had to adjust the prescribed drug dosage, since there were no previous findings available. Patients and Methods: This is a case study of RRP patients treated with CONTOVIR as an adjuvant to the classic treatment, fromMarch 2011 to February 2013, at an academic tertiary hospital (Rasoul-e-Akram hospital). All patients underwent surgical removal ofpapilloma and then were prescribed CONTOVIR. Disease severity was quantified based on Derkay’ s staging system. Results: Eight patients were enrolled in this study. The extent and severity of the disease improved in six cases. One had no response, and the severity of disease increased in one patient. Patients with supraglottic lesions had better responses to CONTOVIR adjuvanttherapy. No immediate or long-term side effects were reported. Conclusions: Although CONTOVIR has been found to be an advantageous adjuvant for RRP treatment, further studies are called forto verify these findings.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FARHADI, MOHAMMAD, IZADI, FARZAD, BAHRI, MARYAM, DERAKHSHANDEH, VITTA, TAVAKOLI, MOHAMMAD MOEIN, KHORRAM KHORSHID, HAMID REZA, MADANI, HESSAMODIN, SHAHRIVAR, ROYA, & AHMADI, ASLAN. (2017). CONTOVIR-A NEW ADJUVANT THERAPY IN RECURRENT RESPIRATORYPAPILLOMATOSIS: A CASE STUDY (RAPID COMMUNICATION). IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 19(12), 0-0. SID. https://sid.ir/paper/293824/en

    Vancouver: Copy

    FARHADI MOHAMMAD, IZADI FARZAD, BAHRI MARYAM, DERAKHSHANDEH VITTA, TAVAKOLI MOHAMMAD MOEIN, KHORRAM KHORSHID HAMID REZA, MADANI HESSAMODIN, SHAHRIVAR ROYA, AHMADI ASLAN. CONTOVIR-A NEW ADJUVANT THERAPY IN RECURRENT RESPIRATORYPAPILLOMATOSIS: A CASE STUDY (RAPID COMMUNICATION). IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2017;19(12):0-0. Available from: https://sid.ir/paper/293824/en

    IEEE: Copy

    MOHAMMAD FARHADI, FARZAD IZADI, MARYAM BAHRI, VITTA DERAKHSHANDEH, MOHAMMAD MOEIN TAVAKOLI, HAMID REZA KHORRAM KHORSHID, HESSAMODIN MADANI, ROYA SHAHRIVAR, and ASLAN AHMADI, “CONTOVIR-A NEW ADJUVANT THERAPY IN RECURRENT RESPIRATORYPAPILLOMATOSIS: A CASE STUDY (RAPID COMMUNICATION),” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 19, no. 12, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/293824/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button